A Dayton-area medical technology firm has received a $15 million growth capital investment from an overseas investor.
Riverain Technologies, a Miamisburg-based firm that develops clinical artificial intelligence software used to detect lung disease at early stages, announced Tuesday it received $15 million from the Ping An Global Voyager Fund — a billion-dollar fund operated by Shenzhen-based finance conglomerate Ping An that invests in growth-stage fintech and health-tech companies.
Click here to read the complete article.
Story excerpt provided by Dayton Business Journal.
Written by Jacob Fisher.
Originally published September 17, 2019.